MEP31308A - Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin - Google Patents
Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecinInfo
- Publication number
- MEP31308A MEP31308A MEP-313/08A MEP31308A MEP31308A ME P31308 A MEP31308 A ME P31308A ME P31308 A MEP31308 A ME P31308A ME P31308 A MEP31308 A ME P31308A
- Authority
- ME
- Montenegro
- Prior art keywords
- liquid preparations
- group
- camptothecin
- lyophilized
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002112864 | 2002-04-16 | ||
| PCT/JP2003/004745 WO2003086471A2 (fr) | 2002-04-16 | 2003-04-15 | Preparation liquide comprenant un derive de camptothecine et composition pharmaceutique pouvant etre preparee par lyophilisation de la preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP31308A true MEP31308A (en) | 2010-10-10 |
Family
ID=29243336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-313/08A MEP31308A (en) | 2002-04-16 | 2003-04-15 | Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050215485A1 (fr) |
| EP (1) | EP1501549A2 (fr) |
| JP (1) | JP3927954B2 (fr) |
| KR (1) | KR100700963B1 (fr) |
| CN (1) | CN100544769C (fr) |
| AR (1) | AR039272A1 (fr) |
| AU (1) | AU2003223120B2 (fr) |
| BR (1) | BR0309283A (fr) |
| CA (1) | CA2480425A1 (fr) |
| HR (1) | HRP20040894A2 (fr) |
| ME (1) | MEP31308A (fr) |
| MX (1) | MXPA04010178A (fr) |
| MY (1) | MY136696A (fr) |
| NO (1) | NO20044964L (fr) |
| PL (1) | PL371677A1 (fr) |
| RS (1) | RS91204A (fr) |
| RU (1) | RU2315623C2 (fr) |
| TW (1) | TW200306314A (fr) |
| UA (1) | UA77295C2 (fr) |
| WO (1) | WO2003086471A2 (fr) |
| ZA (1) | ZA200408008B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005024923D1 (de) * | 2004-02-13 | 2011-01-05 | Yakult Honsha Kk | Wässrige lösung mit einem camptothecin |
| CN1946421B (zh) | 2004-04-27 | 2013-07-17 | 威尔斯达特生物制剂公司 | 使用病毒和喜树碱进行的癌症治疗 |
| RU2435586C2 (ru) | 2005-07-14 | 2011-12-10 | Веллстат Байолоджикс Корпорейшн | Лечение рака с применением вирусов, фторпиримидинов и камптотецинов |
| JP2007260275A (ja) * | 2006-03-29 | 2007-10-11 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びイオントフォレーシス投与用組成物 |
| WO2010151544A1 (fr) | 2009-06-22 | 2010-12-29 | Wyeth Llc | Compositions immunogènes d'antigènes de staphylococcus aureus |
| JP2012530785A (ja) | 2009-06-22 | 2012-12-06 | ワイス・エルエルシー | 組成物および黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）血清型５および８莢膜多糖コンジュゲート免疫原性組成物を調製するための方法 |
| CN102764260B (zh) * | 2011-04-30 | 2014-07-30 | 正大天晴药业集团股份有限公司 | 一种喜树碱衍生物的药物组合物及其制备方法 |
| WO2013011598A1 (fr) * | 2011-07-15 | 2013-01-24 | コニカミノルタホールディングス株式会社 | Préparation contenant des liposomes utilisant un auxiliaire de dissolution et son procédé de fabrication |
| AU2015369185B2 (en) | 2014-12-26 | 2020-10-22 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical preparation of camptothecin-containing polymer derivative |
| KR20180039628A (ko) | 2015-09-03 | 2018-04-18 | 니폰 가야꾸 가부시끼가이샤 | 캄프토테신류 고분자 유도체를 함유하는 의약 조성물 |
| AU2016326747A1 (en) | 2015-09-25 | 2018-03-01 | Zy Therapeutics Inc. | Drug formulation based on particulates comprising polysaccharide-vitamin conjugate |
| CN108697806A (zh) * | 2016-03-01 | 2018-10-23 | 日本化药株式会社 | 含有喜树碱类高分子衍生物的药物制剂 |
| CN109481691A (zh) * | 2018-11-20 | 2019-03-19 | 珠海天香苑生物科技发展股份有限公司 | 吉西他滨-羧甲基多糖共轭物、制备方法及其用途 |
| AU2022396967A1 (en) * | 2021-11-26 | 2024-06-13 | Astellas Pharma Inc. | Indocyanine compound-containing solid pharmaceutical composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340817A (en) * | 1987-04-14 | 1994-08-23 | Research Triangle Institute | Method of treating tumors with anti-tumor effective camptothecin compounds |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
| AR030207A1 (es) * | 2000-04-07 | 2003-08-13 | Daiichi Seiyaku Co | Composicion farmaceutica que contiene un derivado de camptotecina y procedimiento de preparacion de la misma |
| AU2001271037A1 (en) * | 2000-07-13 | 2002-01-30 | Daiichi Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing dds compounds |
| TWI313609B (en) * | 2001-08-21 | 2009-08-21 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
-
2003
- 2003-04-01 TW TW092107354A patent/TW200306314A/zh unknown
- 2003-04-09 AR ARP030101238A patent/AR039272A1/es unknown
- 2003-04-11 MY MYPI20031367A patent/MY136696A/en unknown
- 2003-04-15 AU AU2003223120A patent/AU2003223120B2/en not_active Ceased
- 2003-04-15 PL PL03371677A patent/PL371677A1/xx not_active Application Discontinuation
- 2003-04-15 BR BR0309283-6A patent/BR0309283A/pt not_active IP Right Cessation
- 2003-04-15 JP JP2003587152A patent/JP3927954B2/ja not_active Expired - Fee Related
- 2003-04-15 MX MXPA04010178A patent/MXPA04010178A/es active IP Right Grant
- 2003-04-15 CA CA002480425A patent/CA2480425A1/fr not_active Abandoned
- 2003-04-15 US US10/509,912 patent/US20050215485A1/en not_active Abandoned
- 2003-04-15 WO PCT/JP2003/004745 patent/WO2003086471A2/fr active Application Filing
- 2003-04-15 CN CNB038082292A patent/CN100544769C/zh not_active Expired - Fee Related
- 2003-04-15 ME MEP-313/08A patent/MEP31308A/xx unknown
- 2003-04-15 RS YU91204A patent/RS91204A/sr unknown
- 2003-04-15 RU RU2004133349/15A patent/RU2315623C2/ru not_active IP Right Cessation
- 2003-04-15 KR KR1020047016514A patent/KR100700963B1/ko not_active IP Right Cessation
- 2003-04-15 UA UA20041109367A patent/UA77295C2/uk unknown
- 2003-04-15 EP EP03719110A patent/EP1501549A2/fr not_active Withdrawn
-
2004
- 2004-09-29 HR HR20040894A patent/HRP20040894A2/xx not_active Application Discontinuation
- 2004-10-05 ZA ZA200408008A patent/ZA200408008B/en unknown
- 2004-11-15 NO NO20044964A patent/NO20044964L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY136696A (en) | 2008-11-28 |
| CA2480425A1 (fr) | 2003-10-23 |
| RU2004133349A (ru) | 2005-05-27 |
| AU2003223120A1 (en) | 2003-10-27 |
| CN1646172A (zh) | 2005-07-27 |
| AR039272A1 (es) | 2005-02-16 |
| BR0309283A (pt) | 2005-02-15 |
| JP3927954B2 (ja) | 2007-06-13 |
| NO20044964L (no) | 2004-11-15 |
| RU2315623C2 (ru) | 2008-01-27 |
| KR20050000516A (ko) | 2005-01-05 |
| US20050215485A1 (en) | 2005-09-29 |
| AU2003223120B2 (en) | 2006-10-05 |
| PL371677A1 (en) | 2005-06-27 |
| EP1501549A2 (fr) | 2005-02-02 |
| TW200306314A (en) | 2003-11-16 |
| ZA200408008B (en) | 2005-06-13 |
| KR100700963B1 (ko) | 2007-03-28 |
| AU2003223120A2 (en) | 2003-10-27 |
| RS91204A (en) | 2006-12-15 |
| JP2005523329A (ja) | 2005-08-04 |
| WO2003086471A3 (fr) | 2004-04-15 |
| WO2003086471A2 (fr) | 2003-10-23 |
| MXPA04010178A (es) | 2005-06-08 |
| CN100544769C (zh) | 2009-09-30 |
| HRP20040894A2 (en) | 2005-10-31 |
| UA77295C2 (en) | 2006-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP31308A (en) | Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin | |
| DE69601841T2 (de) | Camptothecinderivate | |
| ATE422356T1 (de) | Pharmazeutische zubereitungen | |
| MEP30008A (en) | Sustained release preparations | |
| MEP90708A (en) | New pharmaceutical composition | |
| DE60103050D1 (de) | Spiro[2.4]heptanaminocarbonsäure und ihre derivate | |
| DE69912313D1 (de) | Colchinolderivate als gefässschädigende mittel | |
| BR0211284A (pt) | Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, a respectiva preparação e a respectiva aplicação em terapêutica | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| TR200402656T4 (tr) | Antikanser ajanları olarak faydalı tiyofen türevleri | |
| TR200103476T2 (tr) | A-beta peptid bileşimleri ve bunları hazırlama yöntemleri | |
| FR2743562B1 (fr) | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| HRP20050787A2 (en) | Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid | |
| HRP20080330T3 (en) | Antitumoral compounds based on kahalalide f | |
| EA200300406A1 (ru) | Фармацевтическая композиция дронедарона для парентерального введения | |
| HRP20060023A2 (en) | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
| EA200501129A1 (ru) | Парентеральные композиции пептида для лечения системной красной волчанки | |
| DE60217903D1 (de) | Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen | |
| BR9807506A (pt) | Derivados de amida e composições medicinais dos mesmos | |
| WO2007147372B1 (fr) | Préparation pharmaceutique injectable | |
| BR0304925A (pt) | Compostos, composições farmacêuticas, e, uso dos compostos | |
| DE69701381D1 (de) | Peptid-aldehydderivate als antikoagulierende mittel | |
| TW200509941A (en) | Pharmaceutical solution composition | |
| CY1107483T1 (el) | Παραγωγα πυριδαζινης, η χρηση τους ως φαρμακευτικα σκευασματα και η διαδικασια παρασκευης τους |